Knowing her risk gave Dana-Farber patient, Margo, a choice

A family history led Margo Lindauer to genetic testing—and gave her the chance to make a deeply personal choice on her own terms.

Mother and child resting on couch

Margo Lindauer’s youngest daughter was two when Margo underwent a risk-reducing double mastectomy. For six weeks afterward, Margo couldn’t pick her up.

“Two-year-olds like to be carried all the time,” she recalled. “We would cuddle or someone would put her on my lap.”

That temporary distance was emotionally painful. But Margo had made her decision to proceed with the surgery with her three daughters in mind. She’d learned that a genetic mutation ran in her family and sought testing at Dana-Farber Cancer Institute. The results showed Margo carried an inherited BRCA2 mutation that increased her risk of developing breast cancer. Having that information helped her consider the options before a cancer diagnosis.

Family smiling together with dog
Marion (7), Valea (11), Ella (15), Margo, and Josh.

“I felt knowing that I had the gene and then being able to make a decision accordingly was empowering,” she said.

For years, Margo had worried about breast cancer. Her paternal grandmother died of the disease in her early 50s, and two of Margo’s close friends received diagnoses in their 30s. Margo had asked about starting screening earlier, but, she said, providers repeatedly reassured her that she was at low risk.

Then, in early 2021, her father, Kenneth Lindauer, received a stage IV prostate cancer diagnosis and began treatment at Dana-Farber. After considering the cancers in their family, his physician encouraged him to pursue genetic testing. Kenneth learned he carried a BRCA2 mutation. Margo sought testing soon afterward and received a positive result two weeks before her 40th birthday.

“I just had a feeling,” she said of waiting for her results.

The finding changed the conversations Margo could have with her care team. Inherited BRCA2 mutations can increase the risk of breast, ovarian, prostate, and other cancers, and a person can inherit one from either parent. People who carry a mutation may consider earlier or more intensive screening, among other ways to manage their risk.

Dana-Farber Patient Smiling

Margo began breast screening with a mammogram and MRI, then had biopsies to investigate areas of concern. She knew she could continue with regular screening, but frequent imaging and uncertain results weighed on her.

She remembered thinking, “I don’t want to live like this.”

Margo chose a risk-reducing double mastectomy with reconstruction in September 2021. She had recently finished breastfeeding her youngest daughter and felt ready to make the decision on her own terms.

“There’s something so different and so empowering about making a decision affirmatively versus being told that you have a protocol that you need to follow to save your life,” she said.

In the months leading up to surgery, Margo also noticed a change in her breasts after weaning her youngest daughter. She had breastfed her older children and felt that this experience was different. She raised the concern with her care team.

During surgery, her team identified concerning cells and changed the planned procedure. Her final pathology showed precancerous cells.

Mother and child smiling

For Margo, the experience reinforced how important it is to take unfamiliar changes seriously. She hopes others will speak up when something changes, even during a stage of life when their bodies may be changing in many ways.

“I also want to empower people like that they are experts in their own bodies,” she said. “When stuff feels different,” it is worth asking about.

Before surgery, Margo met several times with a Dana-Farber therapist. Together, they prepared for her recovery and talked through the emotional effects of her decision. That support shaped how she thinks about philanthropy’s role in cancer care.

“Philanthropic support to Dana-Farber covers things like mental health support before treatment, research grants to improve the science and quality of life outcomes of patients, and, most importantly, access to those who may not qualify for Dana Farber services based on their insurance,” she said. “Everyone deserves the best care for their family—philanthropic dollars help Dana-Farber meet that need.”

Margo knows the same decision would not be right for everyone. She hopes her experience encourages others to learn their family history, discuss changes with a healthcare provider, and seek the information they need to consider their options.

“I’m a big believer that information is power,” she said. For Margo, knowing her risk did not make the choice simple. It gave her the chance to make it for herself.

Readers can explore Dana-Farber’s breast cancer screening recommendations and learn how its Mammography Van brings screening and breast health education into Boston-area communities. Dana-Farber’s Young and Strong Program offers care and support tailored to young adults with breast cancer. Readers can also learn about breast cancer disparities and Dana-Farber’s efforts to address them.

Since 1948, the generosity of millions of people has helped the Jimmy Fund save countless lives and reduce the burden of cancer for patients and families worldwide through community-based fundraising events and other programs that solely and directly benefit Dana-Farber. Learn more about how you can get involved at JimmyFund.Org, and follow the Jimmy Fund on Facebook, X (formerly Twitter), and Instagram: @TheJimmyFund.